JPH0125723B2 - - Google Patents

Info

Publication number
JPH0125723B2
JPH0125723B2 JP56013523A JP1352381A JPH0125723B2 JP H0125723 B2 JPH0125723 B2 JP H0125723B2 JP 56013523 A JP56013523 A JP 56013523A JP 1352381 A JP1352381 A JP 1352381A JP H0125723 B2 JPH0125723 B2 JP H0125723B2
Authority
JP
Japan
Prior art keywords
emorphazone
inflammatory
effect
phenylbutazone
steroidal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56013523A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57128627A (en
Inventor
Makoto Sato
Isami Kimura
Azuma Yamaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Morishita Pharmaceuticals Co Ltd
Original Assignee
Morishita Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Morishita Pharmaceuticals Co Ltd filed Critical Morishita Pharmaceuticals Co Ltd
Priority to JP56013523A priority Critical patent/JPS57128627A/ja
Priority to US06/342,963 priority patent/US4379148A/en
Priority to DE8282300435T priority patent/DE3261724D1/de
Priority to EP82300435A priority patent/EP0059031B1/en
Publication of JPS57128627A publication Critical patent/JPS57128627A/ja
Publication of JPH0125723B2 publication Critical patent/JPH0125723B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP56013523A 1981-01-30 1981-01-30 Analgesic and antiphlogistic composition Granted JPS57128627A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP56013523A JPS57128627A (en) 1981-01-30 1981-01-30 Analgesic and antiphlogistic composition
US06/342,963 US4379148A (en) 1981-01-30 1982-01-26 Analgesic and anti-inflammatory composition
DE8282300435T DE3261724D1 (en) 1981-01-30 1982-01-28 Analgesic and anti-inflammatory composition
EP82300435A EP0059031B1 (en) 1981-01-30 1982-01-28 Analgesic and anti-inflammatory composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56013523A JPS57128627A (en) 1981-01-30 1981-01-30 Analgesic and antiphlogistic composition

Publications (2)

Publication Number Publication Date
JPS57128627A JPS57128627A (en) 1982-08-10
JPH0125723B2 true JPH0125723B2 (https=) 1989-05-19

Family

ID=11835506

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56013523A Granted JPS57128627A (en) 1981-01-30 1981-01-30 Analgesic and antiphlogistic composition

Country Status (4)

Country Link
US (1) US4379148A (https=)
EP (1) EP0059031B1 (https=)
JP (1) JPS57128627A (https=)
DE (1) DE3261724D1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5792886A (en) * 1997-01-08 1998-08-11 Albemarle Corporation Production of racemic 2-(6-methoxy-2-naphthyl) propionic acid of precursors thereof
US6080888A (en) * 1997-01-08 2000-06-27 Albemarle Corporation Preparation of olefinic compounds and carboxylic derivatives thereof
US6096920A (en) * 1997-01-08 2000-08-01 Albemarle Corporation Preparation of carboxylic compounds and their derivatives
WO2015157729A1 (en) * 2014-04-11 2015-10-15 Wilmink Michael Pharmaceutical formulations an comprising analgesic agent, a nonsteroidal anti-inflammatory agent, a gastric acid production suppressant and an anti-nauseant

Also Published As

Publication number Publication date
US4379148A (en) 1983-04-05
JPS57128627A (en) 1982-08-10
EP0059031B1 (en) 1985-01-02
EP0059031A1 (en) 1982-09-01
DE3261724D1 (en) 1985-02-14

Similar Documents

Publication Publication Date Title
US4446140A (en) Method and composition for treating mouth pain
EP0185420B1 (en) Dihydrocodeine/ibuprofen pharmaceutical compositions and method
JP6139743B2 (ja) ロキソプロフェン含有医薬組成物
US3988466A (en) Prevention of gastric lesions
US4016268A (en) Method of combatting gastric ulceration
AU664574B2 (en) Medicaments for treating inflammatory conditions or for analgesia
EP0186241A1 (en) Hydrocodone/ibuprofen pharmaceutical compositions and method
JP3122748B2 (ja) イブプロフェン含有解熱鎮痛剤
Tries et al. The pharmacological profile of ML3000: A new pyrrolizine derivative inhibiting the enzymes cyclo-oxygenase and 5-lipoxygenase
JPH0125723B2 (https=)
HU195110B (en) Process for production of new compositions hindering inflammation containing piroxamate
US3993767A (en) Compositions to suppress gastric bleeding in indomethacin and phenylbutazone therapy
CA1307739C (en) Anti-inflammatory compositions
CA1124648A (en) Anti-inflammatory combination having reduced ulcerogenicity
JPS648602B2 (https=)
CN108992456A (zh) 含有香叶木苷硫酸酯衍生物的药物组合物及其应用
US4036957A (en) Phenoxy compounds in combinations to suppress gastric bleeding in aspirin therapy
US4874757A (en) Antinflammatory compositions and methods
EP0259047A1 (en) Pharmaceutical compositions containing non-steroidal anti-inflammatory drugs
CA2020171C (en) Gastroprotective pharmaceutical preparations containing n-benzyl-n-((1s,5s)-6,6-dimethylbicyclo[3,1,1]-hept-2-ylethoxy-ethyl)-morpholinium salts
EP0178122B1 (en) Improved piroxicam-containing antiinflammatory compositions
EP0013783A1 (en) Protection of the gastric mucosal lining from damage by aspirin and related drugs
WO2019098983A1 (en) Combinations of diclofenac, h2 receptor antagonists and alkali metal bicarbonates for the treatment of pain and inflammation
US4812455A (en) Antiinflammatory compositions and methods
Friedman Trimoprostil (RO-21-6937).